Falk, Steffi S. I. http://orcid.org/0000-0003-0584-343X
Maksimow, Anna
Mittlmeier, Thomas
Gradl, Georg
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 25 January 2023
Accepted: 12 March 2023
First Online: 27 March 2023
Declarations
:
: Steffi S.I. Falk and Anna Maksimow have no relevant financial or non-financial interests to disclose. Thomas Mittlmeier Funding: BMBF, 2017–2020.—Travel expenses, speaker fees: Johnson & Johnson DePuy Synthes (surgical technique courses), AO Germany seminars (surgical courses), BDC courses fracture care, Aesculap Academy.—Co-owner patent: FH Orthopedics, Mulhouse. Georg Gradl Co-developer for the Targon DR, Managing Director of MORE Medical, Germany.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Rostock, Germany.
: All patients signed an informed consent.